A detailed history of Blue Whale Capital LLP transactions in Danaher Corp stock. As of the latest transaction made, Blue Whale Capital LLP holds 185,500 shares of DHR stock, worth $45.5 Million. This represents 4.14% of its overall portfolio holdings.

Number of Shares
185,500
Previous 203,000 8.62%
Holding current value
$45.5 Million
Previous $50.7 Million 8.57%
% of portfolio
4.14%
Previous 5.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$235.51 - $267.98 $4.12 Million - $4.69 Million
-17,500 Reduced 8.62%
185,500 $46.3 Million
Q1 2024

May 14, 2024

BUY
$224.58 - $256.19 $336,870 - $384,285
1,500 Added 0.74%
203,000 $50.7 Million
Q4 2023

Feb 13, 2024

BUY
$185.1 - $233.13 $15.1 Million - $19 Million
81,500 Added 67.92%
201,500 $46.6 Million
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $10.3 Million - $11.7 Million
44,000 Added 57.89%
120,000 $29.8 Million
Q2 2023

Aug 10, 2023

BUY
$224.99 - $256.14 $17.1 Million - $19.5 Million
76,000 New
76,000 $18.2 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $179B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Blue Whale Capital LLP Portfolio

Follow Blue Whale Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Whale Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Whale Capital LLP with notifications on news.